How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264
NVIDIA AI Podcast
00:00
AI Revolution in Drug Development
This chapter explores the shift from traditional drug development methods to AI-driven techniques, emphasizing the benefits of predictive models and case studies like protein design for sickle cell disease. It highlights how AI enhances diagnostic accuracy, streamlines processes, and improves success rates in the drug discovery landscape.
Transcript
Play full episode
